Inductive Bio

Inductive Bio is a technology company that democratizes artificial intelligence (AI) models to transform small molecule drug discovery. They have developed a collaborative AI platform that dramatically accelerates compound optimization, which is a critical step in developing new therapeutics by mapping the drivers of small molecule ADMET.

Funding Round: Series A

Funding Amount: $25M

Date: 07-May-2025

Investors: Obvious Ventures, Andreessen Horowitz (a16z) Bio + Health, Lux Capital, S32, Character, Amino Collective, Oren Etzioni, Jeff Hammerbacher, Malay Gandhi, Jakob Uszkoreit

Markets: AI, Biotech, Healthtech

HQ: San Francisco, California, United States

Founded: 2022

Website: https://www.inductive.bio/

LinkedIn: https://www.linkedin.com/company/inductive-bio

Twitter: https://twitter.com/inductive_bio

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/inductive-bio

Pitchbook: https://pitchbook.com/profiles/company/517972-06